Who loves their new territory? Who believes 15 more reps will counteract a Keytruda indication successfully? Ha Ha. My territory got hacked.
-
IMPORTANT: Need help navigating the boards? Click here for help.
If you have any questions or issues with the boards since our recent upgrade, please post them on the Ask the Webmaster board, or contact us here
Libtayo expansion
- Thread starter anonymous
- Start date
-
- Tags
- None
This organization needs to exit oncology. This is another $%^& show like their previous attempt to enter the oncology arena. They are clueless and have no idea what they are doing. People have left and will continue to do so.
And Praul-u-crap. Never made money, never will. Can’t give that crap away. Snake oil.
Going to be hard to fill the expansion roles if you have to keep backfilling the existing ones.
At least staffing has some job security.
At least staffing has some job security.
People are still interviewing like crazy and will as soon as they get back from the holidays. Let the resignations flow......
real answers
Why do Sanofi and Libtayo management dislike each other? How do you expect the sales teams to produce results with our leaders acting like spoiled children in the sandbox fighting for the spotlight and credit?
As we all know...this is common with most pharma joint ventures. This will work itself out over time.
Well let's see.....
Libtayo= $50million/qtr
Keytruda=$3billion/qtr
Keytruda will get CSCC indication by June but most likely before that date. When that happens, Libtayo will be toast. Merck knows a thing or two about contracts and their salesforce outnumbers ours. We're expanding but it will be way too late. They also have engaged many key academic centers in the keynote 630 trial which will get KOL's using Keytruda immediately.
Management: Ahaaaaahaaaaahaaaaaaaaa.................they are clueless. This place is primary care. Growth goals are steep and unattainable for many.
So if I understand what you’re saying, Metoomavab’s days are numbered. So glad this asshat management team did not think I was the right fit.
This drug is a dog. Most the clinical trials discontinued since we were hired. It’s not the big we signed up for. Basal/cervical/lung all scrapped or years behind. At least the pay is average and we barely work at HQ, management and sales. Someday soon the gravy train will end when Pembro gets approved and we are all laid off or shuffled to another drug.
There’s a foul odor coming from the oncology BU- smells like death.
The foul odor is probably blowing over from the Pralucrap team.
The stench from oncology BU is unbearable. Need to clean house and cleanup that mess. It’s only going to get worse with time.
Libtato is a bust. How long before “field staffers” get the boot?